E-MAIL: your-email@mail.com
E-MAIL: your-email@mail.com
Roche strengthens cancer diagnostic portfolio with the launch of the VENTANA BAP1 (SP527) test for differential diagnosis of mesothelioma.
imphoenix82
Abbott’s next-generation Oncodetect MRD test analyses tumour-specific DNA markers in blood samples to help detect residual disease and assess cancer recurrence risk during and after treatment.
imphoenix82HealthXplore is a digital platform dedicated to delivering insights into what’s new and what’s next in healthcare, pharmaceuticals, and medical innovation. We aim to bridge the gap between complex industry developments and informed audiences by presenting credible, timely, and engaging content.
Contact: +91 9354115542
HealthXploreIndia @2026. All Rights Reserved.
